HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiang Feng Selected Research

metuximab

6/2009A novel antibody fragment targeting HAb18G/CD147 with cytotoxicity and decreased immunogenicity.
6/2007HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
2/2007A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.
6/2006Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
3/2006Biodistribution and localization of iodine-131-labeled metuximab in patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiang Feng Research Topics

Disease

87Neoplasms (Cancer)
05/2024 - 10/2005
17Inflammation (Inflammations)
01/2024 - 06/2016
17Neoplasm Metastasis (Metastasis)
10/2023 - 02/2007
10Breast Neoplasms (Breast Cancer)
10/2023 - 10/2012
10Infections
03/2022 - 01/2013
9Coronary Disease (Coronary Heart Disease)
01/2023 - 10/2016
8Sepsis (Septicemia)
10/2022 - 09/2014
8Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2015
8Body Weight (Weight, Body)
01/2021 - 03/2006
7Carcinoma (Carcinomatosis)
10/2023 - 10/2005
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2006
6Diabetes Mellitus
12/2023 - 01/2019
6Atherosclerosis
04/2023 - 12/2021
6Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2006
5Melanoma (Melanoma, Malignant)
10/2023 - 08/2016
4Fibrosis (Cirrhosis)
01/2024 - 02/2007
4Periodontitis
12/2023 - 01/2020
4Prostatic Neoplasms (Prostate Cancer)
02/2023 - 06/2018
4Obesity
01/2023 - 06/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 05/2020
3Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2023
3ST Elevation Myocardial Infarction
12/2023 - 01/2020
3Hypertension (High Blood Pressure)
10/2023 - 07/2018
3Coronary Stenosis (Coronary Artery Stenosis)
01/2023 - 04/2021
3Dysbiosis
01/2023 - 10/2012
3Pathologic Constriction (Stenosis)
01/2023 - 01/2022
3Pneumonia (Pneumonitis)
10/2022 - 02/2016
3Type 2 Diabetes Mellitus (MODY)
11/2017 - 10/2012
3Weight Loss (Weight Reduction)
07/2017 - 09/2015
2Cataract (Cataracts)
04/2024 - 01/2021
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2023 - 11/2018
2Cardiotoxicity
09/2023 - 04/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2023 - 04/2021
2Bites and Stings (Sting)
08/2023 - 01/2021
2Hemorrhage
01/2023 - 01/2020
2Cross Infection (Nosocomial Infection)
10/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2024 - 03/2005
15Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2015
10C-Reactive ProteinIBA
12/2023 - 06/2020
10LipidsIBA
04/2023 - 01/2015
9CytokinesIBA
11/2023 - 01/2019
9MicroRNAs (MicroRNA)IBA
01/2023 - 12/2014
8AntigensIBA
01/2022 - 01/2006
7Interleukin-6 (Interleukin 6)IBA
04/2022 - 01/2020
7Messenger RNA (mRNA)IBA
01/2022 - 01/2014
6Peptides (Polypeptides)IBA
05/2024 - 10/2012
6Long Noncoding RNAIBA
02/2023 - 03/2021
6VaccinesIBA
03/2020 - 01/2013
5CholesterolIBA
12/2023 - 07/2009
5Small Interfering RNA (siRNA)IBA
03/2015 - 10/2012
5metuximabIBA
06/2009 - 03/2006
4omega-Chloroacetophenone (Mace)IBA
12/2023 - 04/2021
4IodineIBA
11/2023 - 03/2006
4Doxorubicin (Adriamycin)FDA LinkGeneric
09/2023 - 01/2013
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 06/2020
4Interleukin-17 (Interleukin 17)IBA
06/2022 - 03/2021
4InterleukinsIBA
06/2022 - 06/2020
4DNA (Deoxyribonucleic Acid)IBA
02/2022 - 10/2012
4Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2009
4Monoclonal AntibodiesIBA
04/2017 - 11/2006
3Lactic Acid (Lactate)FDA LinkGeneric
03/2024 - 01/2021
3Indicators and Reagents (Reagents)IBA
01/2024 - 01/2019
3Troponin IIBA
12/2023 - 01/2020
3ProteomeIBA
12/2023 - 01/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 04/2010
3RNA (Ribonucleic Acid)IBA
10/2023 - 01/2022
3LigandsIBA
08/2023 - 06/2014
3PolymersIBA
08/2023 - 07/2013
3Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 01/2013
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2022 - 03/2021
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2022 - 03/2021
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2016
3Glutathione (Reduced Glutathione)IBA
11/2021 - 01/2021
3CreatinineIBA
03/2021 - 06/2020
3MicellesIBA
01/2021 - 10/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014 - 06/2007
2Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
05/2024 - 02/2023
2Polysaccharides (Glycans)IBA
03/2024 - 12/2023
2Protons (Proton)IBA
03/2024 - 01/2022
2LDL CholesterolIBA
12/2023 - 01/2023
2Hypoglycemic Agents (Hypoglycemics)IBA
12/2023 - 01/2020
2Glycoproteins (Glycoprotein)IBA
12/2023 - 11/2006
2Lipid NanoparticlesIBA
11/2023 - 11/2019
2Carcinoembryonic AntigenIBA
10/2023 - 05/2020
2CopperIBA
10/2023 - 09/2015
2Oxygen (Dioxygen)IBA
09/2023 - 09/2015
2InterferonsIBA
08/2023 - 01/2021
2Anti-Infective Agents (Microbicides)IBA
10/2022 - 01/2022

Therapy/Procedure

39Therapeutics
05/2024 - 11/2006
4Percutaneous Coronary Intervention
12/2023 - 01/2020
4Immunotherapy
10/2023 - 01/2021
4Hyperthermic Intraperitoneal Chemotherapy
08/2021 - 01/2020
4Cytoreduction Surgical Procedures
08/2021 - 01/2020
3Stents
12/2023 - 01/2022
3Drug Therapy (Chemotherapy)
10/2023 - 01/2017
3Photothermal Therapy
09/2023 - 01/2020
3Lasers (Laser)
09/2023 - 03/2011
3Oral Administration
01/2023 - 01/2019
3Adjuvant Chemotherapy
01/2022 - 06/2013
3Radioimmunotherapy
11/2006 - 03/2006